Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B

참고문헌 (14)

1. Liaw YF, "Hepatitis B virus infection", Lancet, 373, pp.582~592 (2009)
2. Chen DS., "From hepatitis to hepatoma: lessons from type B viral hepatitis", Science, 262, pp.369~370 (1993)
3. Chen CJ, "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level", JAMA, 295, pp.65~73 (2006)
4. Iloeje UH, "Predicting cirrhosis risk based on the level of circulating hepatitis B viral load", Gastroenterology, 130, pp.678~686 (2006)
5. Lin CL, "Hepatitis B viral factors and treatment responses in chronic hepatitis B", J Formos Med Assoc, 112, pp.302~311 (2013)
6. Chan HL, "Hepatitis B surface antigen quantification: why and how to use it in 2011: a core group report", J Hepatol, 55, pp.1121~1131 (2011)
7. Su TH, "Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B", Antivir Ther, 15, pp.1133~1139 (2010)
8. Brunetto MR, "Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers", Gastroenterology, 139, pp.483~490 (2010)
9. Tseng TC, "Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters", Gastroenterology, 141, pp.517.e1~525.e2 (2011)
10. Tangkijvanich P, "Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B", J Clin Virol, 46, pp.117~123 (2009)
11. Lee MH, "Correlation of serum hepatitis B surface antigen level with response to entecavir in naive patients with chronic hepatitis B", J Med Virol, 83, pp.1178~1186 (2011)
12. 조주연, "Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response", The Korean Journal of Internal Medicine, 32(4), pp.636~646 (2017), 대한내과학회[DOI]
13. Lee MH, "Prediction models of longterm cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles", Hepatology, 58, pp.546~554 (2013)
14. Tseng TC, "High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load", Gastroenterology, 142, pp.1140.e3~1149.e3 (2012)

관련 논문AI추천